AI used to speed up search for motor neurone disease drugs
Researchers are using AI to spot existing drugs that might treat MND and other brain conditions, hoping to find treatments faster.
The BBC reports that scientists in Edinburgh are combining AI with patient data, lab-grown brain cells and clinical trials to hunt for drugs that can be repurposed for neurological disease. The promise is faster, cheaper treatment discovery.
Some scientists are using computers to look for medicine that already exists but might help with brain illnesses too.
It is like searching through a big toy box to find a toy that can also be used in a new game. The computer helps sort through the boxes much faster than people can by hand.
They also test medicines on tiny groups of brain cells grown in a lab. If a medicine looks promising there, it can move on to tests in people.
How the research works
The UK Dementia Research Institute in Edinburgh is using AI to analyze voice recordings, eye scans, lab-grown brain cells and other patient data to look for patterns linked to neurological conditions. The goal is to identify existing medicines that could be repurposed for illnesses such as motor neurone disease (MND), Parkinson’s and dementia.
From data to drug candidates
The article says the team builds databases of patient information and uses machine learning to detect signs of change that could indicate future problems. They also grow stem cells into neurones and test existing drugs on them using a mix of robots, lab tools and algorithms. The AI is trained to spot drugs that could shift a disease signature toward a healthy one, and promising candidates can then move into human trials.
Why the researchers are optimistic
Prof Siddarthan Chandran, the institute’s chief executive, says the brain’s complexity has made this kind of work difficult, but AI and new technologies now make it possible to do things that once seemed out of reach. The BBC notes that there are around 1,500 approved drugs already available for other conditions, which raises the chance that one could also help neurological disease if researchers can find it.
The story is framed as cautious optimism. The researchers want to move faster than the traditional drug-development path, which can take more than 10 years, but the article also notes that not every high-profile treatment breakthrough has delivered a major benefit to patients. Even so, the team believes they may be at a turning point.
Key points
- Scientists in Edinburgh are using AI to search for drugs that could treat MND and other brain diseases.
- They analyze patient data including voice recordings, eye scans and brain-cell samples.
- The AI helps identify existing medicines that might be repurposed for neurological conditions.
- Researchers hope the approach could find treatments in years rather than decades.
- The article stresses optimism, but notes that medical breakthroughs still face setbacks.
